July 23 2003
Nucletron B.V., a subsidiary of the Delft Instruments Group, has signed an agreement with AEA Technology QSA Inc. to produce radioactive Iridium 192 sources which are being used in its advanced MicroSelectron II™ products to fight cancer. So far these sources were only produced in Petten and irradiated in ECN’s High Flux Reactor. The agreement has a term of 10 years and a value of over 10 million euro. Production will commence in November 2003 and as of that moment Nucletron will have production capability available both in the Netherlands and the U.S.A., thereby reducing its risks. Nucletron profile Nucletron (http://www.nucletron.com/) is world leader in the field of systems for radiotherapy and is specialised in one of the world’s most innovative products for cancer treatment. Nucletron has 20 offices worldwide including its head office in Veenendaal, the Netherlands. Nucletron has a leading position in the radiotherapy market for afterloaders for more than 25 years. AEA Technology QSA profile AEA Technology QSA Inc. is a USA based subsidiary of AEA Technology plc (AAT.L on the London Stock Exchange). The QSA business is an international market leader of high-quality products for medical, industrial, environmental and research applications with manufacturing sites in USA, Germany and China. QSA’s medical therapeutic products have recently been incorporated into a new branded business segment Auriga Medical™ (http://www.aurigamedical.com/). Delft Instruments profile Delft Instruments N.V. is the holding company of an international group of companies which occupy a leading position in their respective markets with high-quality, high-technology products and services. The Delft Instruments companies develop, produce, sell and service advanced (precision) hardware and software for medical and industrial customers. Medical applications include radiation treatment for cancer, X-ray and ultrasound diagnostics and digital archiving of X-ray images. Industrial applications include control and management of storage and transport of oil and gas products. Delft Instruments develops custom-specific total solutions, integrating software, hardware, maintenance and service. Delft Instruments employs some 1,200 people, is listed on Euronext Amsterdam and is included in the NextEconomy segment. The company reported net profit of euro 10,9 million on turnover of euro 194 million in 2002. Executive board of Delft Instruments N.V. Delft, 7 July 2003
For further information: E.H. de Groot, Chairman of the Board Phone: +31 15 2601206 Email: ehdegroot@delftinstruments.nl
Website address: http://www.delftinstruments.com/